Allena Pharmaceuticals IncのNet debt/EBITDA

Allena Pharmaceuticals IncのNet debt/EBITDAは何ですか。

Allena Pharmaceuticals IncのNet debt/EBITDAは1.47です。

Net debt/EBITDAの定義は何ですか。



The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.

The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.

Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization

Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.

NASDAQのセクタHealth CareにおけるNet debt/EBITDAの企業と比べるAllena Pharmaceuticals Inc

Allena Pharmaceuticals Incと類似のnet debt/ebitda